September 12, 2025

Why equipment leasing shapes business choices in unexpected ways

Leasing equipment can safeguard liquidity and unlock flexibility, but investors must weigh whether it signals capital discipline or a hidden long-term cost...

Likewise signals its ambitions with expanding scale

Likewise Group is translating top line momentum into profitability while building the infrastructure to support sales far beyond £200 million...

Peoplevoice Ai Employee Intelligence

PeopleVoice offers a predictive approach to workforce intelligence, turning employee data into actionable insights that link culture, retention, and performance directly to corporate strategy...

Tekmar steadies its course with fresh momentum in offshore energy

Tekmar signals a turning point as it balances cost discipline with a major Middle East contract win worth over ten million dollars...

9.6% dividend yield: RECI is one of the UK top dividend stocks

Real Estate Credit Investments posted a dividend yield of 9.6% in its August 2025 factsheet, with a diversified portfolio of 23 investments valued at £307.9m. The company committed £17.1m during..

Emerging markets reveal a shift

Emerging markets are drawing renewed investor attention as currency shifts, valuations, and policy support converge to create conditions not seen in years...

Copper poised amid rates and supply disruption

Copper is gaining strength as hopes for US rate cuts meet growing supply disruptions at Grasberg, putting the market at a pivotal moment...

A Rare Moment for Gold

Gold has surpassed its inflation-adjusted 1980 peak and with UBS forecasting $3,800 per ounce by 2025, miners are racing to expand production as investors reassess positioning...

Kamada Ltd. (KMDA) Investor Outlook: Exploring a Potential 99.57% Upside

Kamada Ltd. (NASDAQ: KMDA), an Israeli healthcare company specializing in plasma-derived protein therapeutics, has emerged as an intriguing prospect for investors in the drug manufacturing sector, especially given its impressive..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Exploring a 65.75% Potential Upside in the Biotech Sector

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) has captured the attention of investors with its ambitious strides in the biotechnology sector. With a market capitalization of $1.05 billion, this clinical-stage biopharmaceutical company..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a 58.73% Potential Upside

Individual investors seeking opportunities in the healthcare sector, particularly in regenerative medicine, may find Organogenesis Holdings Inc. (NASDAQ: ORGO) an intriguing prospect. This Massachusetts-based company specializes in developing, manufacturing, and..

AngioDynamics, Inc. (ANGO) Investor Outlook: A 66% Potential Upside Amidst Healthcare Innovation

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector, specializes in the design and manufacturing of advanced medical, surgical, and diagnostic devices. With a focus on treating peripheral..

Treace Medical Concepts, Inc. (TMCI): Investor Outlook with a 15% Upside Potential Amid Revenue Growth

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a key player in the healthcare sector specializing in medical devices, is drawing attention with its innovative solutions for bunion and midfoot deformities. Founded..

Precigen, Inc. (PGEN) Stock Analysis: Unveiling a 99% Upside Potential

In the ever-evolving landscape of biotechnology, Precigen, Inc. (NASDAQ: PGEN) has emerged as a notable player, captivating investor interest with its innovative approach to gene and cell therapies. As a..

Myriad Genetics (MYGN) Stock Analysis: Navigating Earnings Challenges and Market Opportunities

Myriad Genetics, Inc. (NASDAQ: MYGN) operates at the intersection of molecular diagnostics and precision medicine, offering an extensive array of genetic testing services. Despite its innovative portfolio, Myriad’s financial performance..

Oruka Therapeutics, Inc. (ORKA)

⚠️ No article content returned.

..

Altimmune, Inc. (ALT) Stock Analysis: Exploring a 366% Potential Upside in Biotech Innovation

Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, stands at a fascinating juncture with a compelling potential upside of 366.12%. As a player in the biotechnology sector, Altimmune focuses on..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Challenges in the Healthcare Sector

Sonida Senior Living, Inc. (NASDAQ: SNDA), a prominent player in the healthcare sector, operates senior housing communities across the United States. With a market capitalization of $490.34 million, the company..

Prothena Corporation plc (PRTA) Stock Analysis: Exploring a 42% Upside Potential in Biotech Innovation

Prothena Corporation plc (NASDAQ: PRTA) is carving a niche for itself in the biotechnology sector with a focus on innovative therapies for diseases caused by protein dysregulation. Based in Dublin,..

SIGA Technologies Inc. (SIGA): Investor Outlook on a High-Growth Pharma Player with Robust Revenue Surge

SIGA Technologies Inc. (NASDAQ: SIGA), a noteworthy player in the healthcare sector, is capturing investor attention with its remarkable revenue growth. As a commercial-stage pharmaceutical company, SIGA specializes in the..

Search

Funds

September 12, 2025

Why equipment leasing shapes business choices in unexpected ways

Leasing equipment can safeguard liquidity and unlock flexibility, but investors must weigh whether it signals capital discipline or a hidden long-term cost...

Likewise signals its ambitions with expanding scale

Likewise Group is translating top line momentum into profitability while building the infrastructure to support sales far beyond £200 million...

Peoplevoice Ai Employee Intelligence

PeopleVoice offers a predictive approach to workforce intelligence, turning employee data into actionable insights that link culture, retention, and performance directly to corporate strategy...

Tekmar steadies its course with fresh momentum in offshore energy

Tekmar signals a turning point as it balances cost discipline with a major Middle East contract win worth over ten million dollars...

9.6% dividend yield: RECI is one of the UK top dividend stocks

Real Estate Credit Investments posted a dividend yield of 9.6% in its August 2025 factsheet, with a diversified portfolio of 23 investments valued at £307.9m. The company committed £17.1m during the month to support the lease-up of a Canary Wharf office building, while net effective leverage stood at 34.7%..

Emerging markets reveal a shift

Emerging markets are drawing renewed investor attention as currency shifts, valuations, and policy support converge to create conditions not seen in years...

Copper poised amid rates and supply disruption

Copper is gaining strength as hopes for US rate cuts meet growing supply disruptions at Grasberg, putting the market at a pivotal moment...

A Rare Moment for Gold

Gold has surpassed its inflation-adjusted 1980 peak and with UBS forecasting $3,800 per ounce by 2025, miners are racing to expand production as investors reassess positioning...
Search

Funds

September 12, 2025

FTSE 100

Funds